Chief IP Counsel
Regulatory Challenges to Life Science IP's
Tuesday, November 27th, 2018
Address public perception of companies’ patenting strategies and their impact on competition, Combined more recently with that of overpriced medicines, is putting tremendous pressure for change on our industry,
Need to be proactive to show core value of patents for policymakers who see weakening IP as a boon to patients and payer budgets.
UCB will show how to put this belief into practice by optimizing patent portfolio to only file and retain those patents that demonstrate clear value